Form 4: Director Brill Receives CVV Stock Grant

CVD Equipment Corp. Director Dr. Robert M. Brill was granted 11,100 shares of common stock as part of the company's director compensation plan.

Summary

• Dr. Robert M. Brill, a Director of CVD Equipment Corp. (CVV), was granted 11,100 shares of common stock.
• The grant occurred on August 8, 2025, coinciding with the company's 2025 Annual Meeting of Shareholders.
• The shares were granted at a price of $0, indicating an automatic award under the company's Director Compensation Plan and 2022 Share Incentive Plan.
• Following this transaction, Dr. Brill's direct beneficial ownership increased to 46,546 shares of common stock.
• The granted shares will vest quarterly on September 30, 2025, December 31, 2025, March 31, 2026, and June 30, 2026, contingent on Dr. Brill's continued service as a Director.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. It's a routine compensation event, indicating stability in governance and alignment of interests, but not a significant market-moving event.

Positives

• The grant aligns the director's interests with shareholders through equity ownership.
• It indicates a standard compensation practice for directors, reflecting ongoing commitment to corporate governance.

Negatives

• Minor dilution of existing shares due to the issuance of new shares for compensation.
• The grant is compensation, not an open market purchase, which might be seen as a stronger signal of confidence.

Future Outlook

The filing indicates future vesting dates for the granted shares, contingent on the director's continued service, extending through June 30, 2026.

Industry Context

This Form 4 filing reports a routine equity compensation grant to a director, a common practice across industries to align management and director interests with shareholders. It does not provide broader industry-specific insights.

Comparison to Industry Standards

• Equity grants to directors are a standard component of compensation packages across publicly traded companies, aiming to foster long-term commitment and align interests.
• The specific number of shares and vesting schedule are typical for such plans, though the exact value would depend on the company's market capitalization and overall compensation philosophy.
• No specific comparable companies or projects are mentioned in this filing.

Corporate Governance

Stakeholder Impact

• Shareholders: Minor dilution from the issuance of new shares for compensation, but improved alignment of director interests.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• Vesting of granted shares on September 30, 2025.
• Vesting of granted shares on December 31, 2025.
• Vesting of granted shares on March 31, 2026.
• Vesting of granted shares on June 30, 2026.

Key Dates

Recommendation

This Form 4 filing reports a routine equity grant to a director as part of a pre-existing compensation plan. It does not provide new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. It primarily indicates ongoing corporate governance and director alignment, which is generally a neutral to slightly positive signal, supporting a 'hold' position for existing investors.

Keywords

CVD Equipment Corp, CVV, Form 4, Insider Transaction, Stock Grant, Director Compensation, Equity Compensation, Beneficial Ownership, SEC Filing